BDSX

MKT CAP:$158M

Biodesix Inc

Market Cap

$158M

Healthcare·Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Diagnostics·🇺🇸·NASDAQ

Stock Price

$15.46+$9.00 (+139.32%)

Jun 5, 2026

52W High $19.4052W Low $5.01

Company Details

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help...

CEO

—

IPO Date

Oct 28, 2020

Website

www.biodesix.com

Key Metrics TTM

Revenue

$96M

+29.1% YoY

Net Income

-$32M

EPS (Diluted)

Free Cash Flow

-$25M

Revenue / Share

$9.95

Gross Margin

82.1%

Operating Margin

-25.9%

Net Margin

-33.3%

FCF Margin

-26.3%

P/S

1.6x

P/E

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 4, 2026

$26M+42.3%

FY 2025

Feb 26, 2026

$88M+24.1%

Q4 2025

Feb 26, 2026

$29M+40.8%

Q3 2025

Nov 3, 2025

$22M+19.9%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee